Product
Vi-Typhoid Conjugate Vaccine
1 clinical trial
1 indication
Indication
TyphoidClinical trial
A Phase III Randomized, Double-Blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, MalawiStatus: Active (not recruiting), Estimated PCD: 2024-10-30